Development of a Stewardship Intervention for CLC Pharmacists to Improve UTI Treatments
Project Number5IK2HX002247-05
Contact PI/Project LeaderAPPANEAL, HALEY J
Awardee OrganizationPROVIDENCE VA MEDICAL CENTER
Description
Abstract Text
In the long-term care (LTC) setting, 70% of residents receive at least one course of antibiotics each year and
up to 75% of this use is reported to be inappropriate or unnecessary. The harms of antibiotic misuse in frail
older LTC residents are significant, including Clostridium difficile infection, adverse drug events and drug
interactions, and colonization and/or infection with resistant bacteria. This crisis has prompted the President of
the United States to formally recognize antibiotic misuse and resistance as a global public health crisis and a
key national security threat. In response, the Centers for Disease Control (CDC) recently outlined Core
Elements to improve antibiotic use in long-term care facilities (LTCFs) and mandate that at least one Core
Element be implemented immediately. While these Core Elements are timely, they are based on data
extrapolated from acute care hospitals, an environment that differs substantially from LTC. Effective and
financially resourceful antibiotic stewardship interventions to improve patient safety in LTCFs remain unknown
and absent, particularly within the VA. As such, there is a critical need for the development of tailored antibiotic
stewardship interventions to improve the care of the 50,000+ Veterans who reside in VA LTCFs (known as
community living centers or CLCs) annually.
Treatment of suspected urinary tract infection (UTI) is the largest contributor to antibiotic use in LTCFs. Much
of this use is unnecessary and/or inappropriate. My recent work showed that over 50% of initial antibiotic
selection for suspected UTI was inappropriate at two VA CLCs. There is a vast amount of literature targeting
providers and nurses evaluating interventions designed to improve the appropriate diagnosis of UTI. However,
focused on diagnosis, these studies have failed to correct inappropriate treatment selection when antibiotics
are truly indicated. This is extremely concerning as true UTIs are the most common cause of hospitalization in
LTC residents and the number one cause of bacteremia. Clinical pharmacists are drug therapy experts and are
ideally suited to correct inappropriate UTI antibiotic therapy. Therefore, I hypothesize that an educational
program targeting CLC pharmacists will lead to improved antibiotic use for UTIs. My long-term goal is to
improve the quality of care of residents nationally through reduction of inappropriate antibiotic use. Accordingly,
the work proposed, creates, implements, and tests a feasible “real world” model for antibiotic stewardship in
VA CLCs. This model places the pharmacist in a prominent antibiotic stewardship role by taking advantage of
a pharmacist’s expertise in guiding appropriate antibiotic use, while using the pharmacist as a consistent
presence for many CLCs. This model was specifically designed with the ability to disseminate this work to VA
CLCs nationally. To improve the utility of this model, interventions will be based off facility-specific antibiotic
use rates and antibiograms. The objectives of this proposal are to pilot test the implementation and
effectiveness of our antibiotic stewardship intervention through three specific aims:
Aim 1. To describe antibiotic use and inappropriate antibiotic use for suspected culture positive UTI among VA
CLCs nationally and identify independent predictors of inappropriate antibiotic use.
Aim 2. To develop an educational intervention targeting CLC pharmacists to reduce inappropriate treatment of
UTIs and pilot test the intervention in two CLCs.
Aim 3. To evaluate the effectiveness of the educational intervention on UTI related antibiotic use (primary
outcome), and the frequency of inappropriate antibiotic use, and absence of de-escalation by day 4.
The proposed research is significant, because it is expected to result in an intervention that can be
disseminated broadly to effectively improve antibiotic use, and ultimately improve resident safety through
reduction of antibiotic resistant infections in CLCs nationally.
Public Health Relevance Statement
Studies suggest that up to 75% of the antibiotics used in long-term care facilities are incorrectly prescribed, a
finding that likely contributes to the rapid growth in antibiotic resistant bacteria in this setting. Despite advances
in VA acute care hospitals, antibiotic stewardship, defined as any activity that optimizes antibiotic use or stops
unnecessary use, is largely absent in VA long-term care facilities (CLCs). This proposal seeks to develop and
implement an educational intervention targeting CLC pharmacists to improve antibiotic use for urinary tract
infections, thus having a positive impact on the public health through improving the care and safety of our
Veterans residing in CLCs and our nation’s population at large.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccountabilityAdverse drug eventAdvisory CommitteesAlgorithmsAntibiotic TherapyAntibioticsAwardBackBacteremiaBacterial Antibiotic ResistanceCLC GeneCaringCenters for Disease Control and Prevention (U.S.)Clinical PharmacistsClostridium difficileCommunicable DiseasesComplexDataData ReportingDatabasesDevelopmentDiagnosisDoseDrug InteractionsEducationEducational InterventionEffectivenessElementsEngineeringEnsureEnvironmentFeedbackFoundationsFrequenciesFundingFutureGoalsHealth Services ResearchHealth care facilityHepaticHospitalizationHospitalsHumanInfectionInterventionInterviewKidneyLeadershipLiteratureLong-Term CareMeasuresMedical centerMentorshipMethodologyModelingNational SecurityNursesOutcomePatientsPharmaceutical PreparationsPharmacistsPharmacotherapyPharmacy facilityPopulationPositioning AttributeProviderPublic HealthQualitative MethodsQuality of CareReportingResearchResearch MethodologyResistanceRoleSafetySecureSelection for TreatmentsSymptomsSystemTestingTimeTrainingUnited StatesUrinary tract infectionVeteransWorkacute careantibiotic resistant infectionsbacterial resistancebasecareercommunity livingdesigneffectiveness evaluationexperienceflexibilityimplementation researchimplementation toolimprovedinformantinnovationpatient safetypilot testprimary outcomeprogramsrapid growthresponsesecondary outcometherapy designtoolunnecessary treatment
No Sub Projects information available for 5IK2HX002247-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5IK2HX002247-05
Patents
No Patents information available for 5IK2HX002247-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5IK2HX002247-05
Clinical Studies
No Clinical Studies information available for 5IK2HX002247-05
News and More
Related News Releases
No news release information available for 5IK2HX002247-05
History
No Historical information available for 5IK2HX002247-05
Similar Projects
No Similar Projects information available for 5IK2HX002247-05